We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


indi banarjee

Dr Indi (Indraneel) Banerjee

Consultant Paediatric Endocrinologist



Special Interests:

Congenital Hyperinsulinism, Puberty


Dr Banerjee is a consultant in Paediatric Endocrinology at the Royal Manchester Children’s Hospital (RMCH) and was appointed to the post in 2006. Dr Banerjee is also the clinical lead for the Northern Congenital Hyperinsulinism (NORCHI) service. This service is for the treatment of the disease of Congenital Hyperinsulinism (CHI), where blood sugar levels can be dangerously low in babies and children. Alongside his interest in CHI, Dr Banerjee also maintains his interest in children and young people with delayed puberty. Dr Banerjee has a number of administrative and teaching roles in the hospital and University. He supervises doctors training to be consultants and is an Academic Advisor to the Medical School. With other members of the paediatric endocrine team and the University of Manchester, he maintains a strong research interest, particularly in the field of CHI. He has published extensively in this area and has helped develop the Royal Manchester Children's Hospital into an international specialist centre for CHI with strong network links with centres in the US, Germany and France.